Checkpoint inhibitors are molecules that modulate the immune response by targeting immune checkpoint pathways. These pathways are critical for maintaining self-tolerance and modulating the duration and amplitude of physiological immune responses. In the context of catalysis, checkpoint inhibitors can be thought of as agents that regulate catalytic activity by interacting with specific sites on the catalyst.
